JDA has completed its acquisition of AI leader Blue Yonder, meaning the software business will be able to integrate Blue Yonder's AI and machine learning tech into its Luminate cognitive SaaS solutions.
JDA wants to automate many of the supply chain elements, helping customers plan, analyse and roll out their supply chain operations on a single platform for retailers and manufacturers.
This includes helping them make better business decisions to speed up the supply chain, offering efficiencies where they're needed most - whether that's financial cut-backs, innovation and customer service improvements or time-related benefits.
It does this by analysing real-time signals such as weather, events and competitive pricing data and applying this to the specific supply chain to predict how every delivery and part of the chain will be affected. This addresses challenges such as spend, inventory, ETAs and other hard-to-determine indicators, making the entire supply chain run more smoothly.
“As we execute on our vision for a truly Autonomous Supply Chain, completing our acquisition of Blue Yonder is a pivotal phase in that journey,” said Desikan Madhavanur, chief development officer, JDA. “Blue Yonder will rapidly accelerate the JDA Luminate product roadmap, helping us to continually deliver cognitive solutions that deliver game-changing and impactful business value to our customers. The Blue Yonder portfolio of AI/ML-based capabilities is available here and now to engage and deliver to our customers.”
Following the acquisition, Blue Yonder will be known as Blue Yonder, a JDA Company, but will remain to develop the technologies and serve its existing customers. Neither company has revealed whether Blue Yonder's staff will join JDA.
“Through Blue Yonder’s proven data science capabilities in our AI and ML solutions, we will enable real-time decision-making that unlocks more autonomous, profitable business decisions throughout our customers’ extended enterprises, unleashing the full business impact of intelligent data and systems," Prof. Dr. Michael Feindt, Blue Yonder founder and chief scientific officer said.
